Evaluation of Genetic Mutations of Tumor Suppresser Genes in Colorectal Cancer Patients

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 114-117

  Kubo, Hiroyuki ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; DCC; LOH; p53

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROSA; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 18; COLORECTAL NEOPLASMS; FEMALE; GENES, DCC; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 10744231519     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Stern HS: Contributions of molecular genetics to the clinical management of colorectal cancer. Am J Surg 1996; 171:10-15.
2. Tamura S, Nakamori S, Kuroki T, Sasaki Y, Furukawa H, Ishikawa O, Imaoka S, Nakamura Y: Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma. J Hepatol 1997; 27:669-676.
3. Takami K, Yana I, Kurahashi H, Nishisho I: Multistep carcinogenesis in colorectal cancers. South Asian J Tropical Med Pub Health 1995; 26(Suppl 1):190-196.
4. Sunahara M, Ichimiya S, Nimura Y, Takada N, Sakiyama S, Sato Y, Todo S, Adachi W, Amano J, Nakagawara A: Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol ; 13:319-323.
5. Kataoka M, Okabayashi T, Orita K: Decreased expression of DCC mRNA in gastric and colorectal cancer. Surg Today 1995; 25:1001-1007.
6. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA, Vogelstein B: The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994; 19:525-631.
7. Boland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP: Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nature Med 1995; 1:902-909.
8. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-532.
9. Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale AL, Gaudernack G: Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 1997; 74:664-669.
10. Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A: p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996; 17:2201-2205.
11. Guinee DG Jr, Travis WD, Trivers GE, De Benedetti VM, Cawley H, Welsh JA, Bennett WP, Jett J, Colby TV, Tazelaar H: Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis 1995; 16:993-1002.
12. Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, House A, Iacopetta B: p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res 1997; 3:1405-1411.
13. Lleonart ME, Garcia-Foncillas J, Sanchez-Prieto R, Martin P, Moreno A, Salas C, Ramon y Cajal S: Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications. Cancer 1998; 83:889-895.
14. Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE, Zhuang Z: Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 1997; 89:1448-1453.
15. Arai T, Akiyama Y, Yamamura A, Hosoi T, Shibata T, Saitoh K, Okabe S, Yuasa Y: Allelotype analysis of early colorectal cancers with lymph node metastasis. Int J Cancer 1998; 79:418-423.
16. Gonzalez-Aguilera JJ, Herrero MP, Maillo C, Moreno-Azcoita M, Fernandez-Peralta AM: Loss of heterozygosity of TP53 is not correlated with clinicopathological variables in sporadic colorectal carcinomas. Anticancer Res 1999; 19:1325-1329.
17. Frank CJ, McClatchey KD, Devaney KO, Carey TE: Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 1997; 57:824-827.
18. Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, Imai K, Yachi A: Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer 1993; 53:260-263.
19. Fearon ER, Pierceall WE: The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules. Cancer Surveys 1995; 24:3-17.
20. Martinez-Lopez E, Abad A, Font A, Monzo M, Ojanguren I, Pifarre A, Sanchez JJ, Martin C, Rosell R: Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998; 114:1180-1187.
21. Raymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F: DCC protein as a predictor of distant metastases after curative surgery for rectal cancer. Dis Colon Rectum 1998; 41:755-760.
22. Kersemaekers AM, Renter GG, Hermans J, Fleuren GJ, van de Vijver MJ: Allelic loss and prognosis in carcinoma of the uterine cervix. Int J Cancer 1998; 79:411-417.
23. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele G Jr, Jessup JM, Loda M, Summerhayes IC: The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996; 335:1727-1732.
24. Ogunbiyi OA, Goodfellow PJ, Herfarth K, Gagliardi G, Swanson PE, Birnbaum EH, Read TE, Fleshman JW, Kodner IJ, Moley JF: Confirmation that chromosome q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 1998; 16:427-433.
25. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B, Hamilton SR: Allelic loss of chromosome 18q and prognosis iri colorectal cancer. N Engl J Med 1994; 331:213-221.
26. Chetty R, Naidoo R, Schneider J: Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology. Mole Pathol 1998; 51:35-38.
27. Yoshida Y, Itoh F, Endo T, Hinoda Y, Imai K: Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant. Int J Cancer 1998; 79:634-639.